rs615942
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_025233.7(COASY):c.164C>A(p.Ser55Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.547 in 1,609,410 control chromosomes in the GnomAD database, including 243,392 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.50 ( 19459 hom., cov: 32)
Exomes 𝑓: 0.55 ( 223933 hom. )
Consequence
COASY
NM_025233.7 missense
NM_025233.7 missense
Scores
5
13
Clinical Significance
Conservation
PhyloP100: 5.22
Genes affected
COASY (HGNC:29932): (Coenzyme A synthase) Coenzyme A (CoA) functions as a carrier of acetyl and acyl groups in cells and thus plays an important role in numerous synthetic and degradative metabolic pathways in all organisms. In eukaryotes, CoA and its derivatives are also involved in membrane trafficking and signal transduction. This gene encodes the bifunctional protein coenzyme A synthase (CoAsy) which carries out the last two steps in the biosynthesis of CoA from pantothenic acid (vitamin B5). The phosphopantetheine adenylyltransferase domain of this bifunctional protein catalyzes the conversion of 4'-phosphopantetheine into dephospho-coenzyme A (dpCoA) while its dephospho-CoA kinase domain completes the final step by phosphorylating dpCoA to form CoA. Mutations in this gene are associated with neurodegeneration with brain iron accumulation (NBIA). Alternative splicing results in multiple isoforms. [provided by RefSeq, Apr 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=3.2346416E-5).
BP6
Variant 17-42562786-C-A is Benign according to our data. Variant chr17-42562786-C-A is described in ClinVar as [Benign]. Clinvar id is 379956.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-42562786-C-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.62 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COASY | NM_025233.7 | c.164C>A | p.Ser55Tyr | missense_variant | 1/9 | ENST00000393818.3 | NP_079509.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COASY | ENST00000393818.3 | c.164C>A | p.Ser55Tyr | missense_variant | 1/9 | 1 | NM_025233.7 | ENSP00000377406.1 |
Frequencies
GnomAD3 genomes AF: 0.503 AC: 76366AN: 151876Hom.: 19437 Cov.: 32
GnomAD3 genomes
AF:
AC:
76366
AN:
151876
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.532 AC: 132584AN: 249248Hom.: 35907 AF XY: 0.538 AC XY: 72746AN XY: 135236
GnomAD3 exomes
AF:
AC:
132584
AN:
249248
Hom.:
AF XY:
AC XY:
72746
AN XY:
135236
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.552 AC: 804458AN: 1457416Hom.: 223933 Cov.: 69 AF XY: 0.554 AC XY: 401155AN XY: 724372
GnomAD4 exome
AF:
AC:
804458
AN:
1457416
Hom.:
Cov.:
69
AF XY:
AC XY:
401155
AN XY:
724372
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.503 AC: 76421AN: 151994Hom.: 19459 Cov.: 32 AF XY: 0.501 AC XY: 37210AN XY: 74276
GnomAD4 genome
AF:
AC:
76421
AN:
151994
Hom.:
Cov.:
32
AF XY:
AC XY:
37210
AN XY:
74276
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2093
ALSPAC
AF:
AC:
2186
ESP6500AA
AF:
AC:
1897
ESP6500EA
AF:
AC:
4667
ExAC
AF:
AC:
65057
Asia WGS
AF:
AC:
1992
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 02, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jul 31, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 75% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 70. Only high quality variants are reported. - |
Neurodegeneration with brain iron accumulation 6 Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 22, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Pontocerebellar hypoplasia, type 12 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 22, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;T;T;.;T;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T;.;T;T;T;T
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;.;L;.;.;.;L
PrimateAI
Benign
T
PROVEAN
Benign
.;.;.;.;.;.;.;N
REVEL
Benign
Sift
Benign
.;.;.;.;.;.;.;T
Sift4G
Uncertain
D;D;D;D;D;D;D;D
Polyphen
0.80, 0.94
.;.;.;P;.;.;P;P
Vest4
0.18, 0.10, 0.19
MPC
0.78
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at